CytoCore is a publicly traded biotechnology company that offers screening and diagnosis services for endometrial and cervical cancers. It provides the SoftPAP cervical cell collector, which is a sample collection device. The company offers biochemical assays that are used to identify suspicious and abnormal cells. CytoCore conducts slide-based tests for screening endometrial and cervical cancers. It also provides the Automated Imaging Proteomic System, which is used for analyzing cytological and histological specimen slides. The company offers a drug delivery system that assists physicians in the treatment of cervical lesions. CytoCore uses in vitro diagnostic application of proteomic detection technology. Its products are used in several laboratories and clinics. In addition, the company maintains a network of distributors.
Partial Data by Infogroup (c) 2024. All rights reserved.